Zdrowie i gospodarka · 14/03/1995

FDA to Discuss Methodologies for Comparing Drug and Biological Therapies

The FDA is hosting a meeting to address methodological and regulatory issues in comparing the safety, effectiveness, and cost-effectiveness of different active drug and biological therapies, in response to growing industry demands for comparative data.